Of advanced gastric cancer after curative resection evaluation of intraperitoneal hyperthermic perfusion chemotherapy.docVIP

 PAGE \* MERGEFORMAT 7 Of advanced gastric cancer after curative resection evaluation of intraperitoneal hyperthermic perfusion chemotherapy [Paper Keywords:] advanced gastric cancer; intraperitoneal hyperthermic perfusion chemotherapy; gastric cancer after radical resection [Abstract] Objective: To evaluate the advanced gastric cancer after radical resection of the efficacy of intraperitoneal hyperthermic perfusion. Methods: January 1998 ~ January 2002 our department treated advanced gastric cancer patients after radical resection of 226 cases were divided into experimental group (peritoneal hyperthermic perfusion) of 120 cases and the control group (without making peritoneal perfusion chemotherapy) 106 cases. Analysis of two years the difference between survival rates and adverse reactions. Results: Intraperitoneal hyperthermic perfusion chemotherapy in advanced gastric cancer can be an effective radical resection 1 year, 3-year survival rate increased by 12.64% and 23.94%, with a median survival time extended 23 months, the incidence of bone marrow suppression significantly reduced. Conclusion: Intraperitoneal hyperthermic perfusion chemotherapy in advanced gastric cancer is an effective adjuvant therapy after radical resection. I Division of the advanced gastric cancer after curative resection carried out intraperitoneal hyperthermic perfusion chemotherapy, and its efficacy to track follow-up. Follow-up results will now be reported as follows: 1 Materials and Methods 1.1 Clinical data: Select January 1998 ~ January 2002 our department treated advanced gastric cancer patients after radical resection of 226 cases were randomly selected and divided into experimental group (peritoneal hyperthermic perfusion) of 120 cases and the control group (without making abdominal hyperthermic perfusion) of 106 cases. Case inclusion criteria, (1), previously untreated cases; (2) preoperative gastroscopy done diagnosed as stomach cancer, after exclusion of early g